• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Gregory Vidal: Some Populations Continue to Face Barriers to Care Despite Virtual Options

Video

Minority, low-income, and elderly patients faced greater barriers to care even when it went virtual during the pandemic, according to Gregory Vidal, MD, PhD, medical oncologist specializing in breast cancer at West Cancer Center.

Minority, low-income, and elderly patients faced greater barriers to care even when it went virtual during the pandemic, according to Gregory Vidal, MD, PhD, medical oncologist specializing in breast cancer at West Cancer Center.

Transcript

What are the barriers patients continue to face when it comes to virtual cancer care?

A lot of it is education, comfort; digital savviness is the most limiting factor for my practice. I live and practice in an urban area that's a high minority population, in the Memphis area. Although a lot of my patients and the population have phones, a lot of those phones don't have the technology. They don't have cellular connection—even if they have the smartphone, they're not able to connect with me via that. So, there is that technology savviness that that's been lacking.

And then the elderly population. Some, quite frankly, don't even want to try. If these particular patients have family members, particularly young kids, who are savvy enough to help them through it, that happens. But the elderly [patient] who lives alone, I find that that's a big divide to getting those patients.

And it tends to affect the minority population a little bit more. So therefore, we do see disparities there coming up in terms of those patients now have to come into the center. And those are the patients for who travel is a big deal and trying to get into the center. And then in the pandemic, those are the patients who either are most at risk, because they have chronic illnesses, so they come in and get ill. And because of that, a lot of them stayed home.

And what we're finding out now from a breast cancer perspective is that we're seeing a lot of late diagnoses and more later stage at diagnosis of breast cancer, which then impacts survival. So, it just keeps adding onto itself—compounding. And I think, to speak more specifically to your question, the disparity that it creates for minority, low-income, and elderly patients.

Related Videos
Stephanie L. Graff, MD, an expert on breast cancer
Debra Boyer, MD, MHPE, ATSF.
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Plasminogen is vital in the body's coagulation process and breaking down clots | image credit: peterschreiber.media - stock.adobe.com
ISPOR 2024 Recap
Chris Pagnani, MD, PC
Screenshot of Stephen Freedland, MD, during a video interview
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.